Clinical Trial Update: Radiotherapy & Olaparib in COmbination for Carcinoma of the Oesophagus [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial update evaluating the combination of radiotherapy with olaparib for esophageal cancer; current status is UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer

Drugs mentioned

• Olaparib (Olaparib)

Snippet

Sponsor: The Christie NHS Foundation Trust | Conditions: Carcinoma of the Oesophagus | Phase 1 | Status: UNKNOWN